PELLEPHARM, INC.

Profile

Company Names

PELLEPHARM, INC.

Addresses

101 MISSION STREET, SUITE 2050, SAN FRANCISCO, CA 94105

C/O P. DESTEFANO, 275 MIDDLEFIELD ROAD, SUITE 100, MENLO PARK, CA 94025

C/O PAUL DESTEFANO, 275 MIDDLEFIELD ROAD, SUITE 100, MENLO PARK, CA 94025

C/O P. DESTEFANO 275 MIDDLEFIELD ROAD, STE. 100, MENLO PARK, CA 94025

275 MIDDLEFIELD ROAD, STE. 100, MENLO PARK, CA 94025

Phone Numbers

(510) 502-6144
(650) 815-7404

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$19,614,503.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2018-06-18 
$7,500,000.00 
$7,500,000.00 
$0.00 
Equity 
7
2016-06-13 
$3,249,998.00 
$7,500,000.00 
$4,250,002.00 
Equity 
6
2015-09-15 
$719,680.00 
$719,680.00 
$0.00 
Equity 
5
2015-07-13 
$4,550,000.00 
$4,550,000.00 
$0.00 
Equity 
4
2015-03-26 
$1,750,000.00 
$1,750,000.00 
$0.00 
Equity 
3
2015-01-08 
$118,625.00 
$118,625.00 
$0.00 
Equity 
2
2014-10-09 
$1,250,000.00 
$1,250,000.00 
$0.00 
Equity 
1
2014-06-27 
$476,200.00 
$476,200.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KATRIN 
 
ANDREASSON 
DIRECTOR
PELLEPHARM, INC.
MARK 
 
DE SOUZA 
EXECUTIVE OFFICER, DIRECTOR
PELLEPHARM, INC.   |  MYOTHERIX, INC.   |  NFLECTION THERAPEUTICS, INC.   |  FIBRX DERM, INC.   |  RNADERM THERAPEUTICS, INC.   |  REILLY-S HEMP, INC.   |  ICC HOLDINGS, LLC   |  SEYLANMED LLC   |  FLIGHTPATH BIOSCIENCES, INC.   |  KAMAL THERAPEUTICS, INC.
MARK 
 
DE SOUZA, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
PELLEPHARM, INC.
ERVIN 
 
EPSTEIN 
EXECUTIVE OFFICER, DIRECTOR
PELLEPHARM, INC.
ERVIN 
 
EPSTEIN, M.D. 
DIRECTOR, EXECUTIVE OFFICER
PELLEPHARM, INC.
NEIL 
 
KUMAR 
DIRECTOR
BRIDGEBIO LLC   |  PELLEPHARM, INC.   |  EIDOS THERAPEUTICS, INC.   |  LIANBIO   |  THERAS, INC.
NEIL 
 
KUMAR, PH.D. 
DIRECTOR
PELLEPHARM, INC.
FRANK 
 
MCCORMICK 
DIRECTOR
EXELIXIS INC   |  ADURO BIOTECH   |  ADURO BIOTECH, INC.   |  AVIDITY NANOMEDICINES LLC   |  PELLEPHARM, INC.   |  OLEMA PHARMACEUTICALS, INC.   |  REMEDY PLAN, INC.   |  EXUMA BIOTECH CORP.   |  THERAS, INC.
FRANK 
 
MCCORMICK, PH.D. 
DIRECTOR
PELLEPHARM, INC.
SANUJ 
 
RAVINDDRAN, M.D. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
PELLEPHARM, INC.
JEAN 
 
TANG 
DIRECTOR
PELLEPHARM, INC.
JEAN 
 
TANG, M.D., PH.D. 
DIRECTOR
PELLEPHARM, INC.
JEAN 
Y. 
TANG, M.D., PH.D. 
DIRECTOR
PELLEPHARM, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-07-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-18 
2016-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-13 
2015-10-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-15 
2015-07-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-13 
2015-05-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-08 
2015-04-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-26 
2014-10-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-09 
2014-07-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#